Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Change in Accured Expenses (2023 - 2025)

Historic Change in Accured Expenses for BrightSpring Health Services (BTSG) over the last 3 years, with Q3 2025 value amounting to $60.7 million.

  • BrightSpring Health Services' Change in Accured Expenses rose 147259.07% to $60.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.7 million, marking a year-over-year increase of 11957.98%. This contributed to the annual value of -$144.6 million for FY2024, which is 17466.7% down from last year.
  • Per BrightSpring Health Services' latest filing, its Change in Accured Expenses stood at $60.7 million for Q3 2025, which was up 147259.07% from -$52.1 million recorded in Q2 2025.
  • Over the past 5 years, BrightSpring Health Services' Change in Accured Expenses peaked at $89.7 million during Q3 2023, and registered a low of -$110.5 million during Q2 2024.
  • Moreover, its 3-year median value for Change in Accured Expenses was $8.6 million (2025), whereas its average is $6.0 million.
  • As far as peak fluctuations go, BrightSpring Health Services' Change in Accured Expenses plummeted by 40932.21% in 2024, and later skyrocketed by 147259.07% in 2025.
  • Quarter analysis of 3 years shows BrightSpring Health Services' Change in Accured Expenses stood at $34.3 million in 2023, then plummeted by 84.1% to $5.5 million in 2024, then skyrocketed by 1013.39% to $60.7 million in 2025.
  • Its Change in Accured Expenses stands at $60.7 million for Q3 2025, versus -$52.1 million for Q2 2025 and $8.6 million for Q1 2025.